{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T11:01:46Z","timestamp":1793530906700,"version":"4.5.0"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2025,11,18]],"date-time":"2025-11-18T00:00:00Z","timestamp":1763424000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,11,18]],"date-time":"2025-11-18T00:00:00Z","timestamp":1763424000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001411","name":"Indian Council of Medical Research","doi-asserted-by":"publisher","award":["IIRP-2023-5527"],"award-info":[{"award-number":["IIRP-2023-5527"]}],"id":[{"id":"10.13039\/501100001411","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001843","name":"Science and Engineering Research Board","doi-asserted-by":"publisher","award":["CRG\/2020\/002630"],"award-info":[{"award-number":["CRG\/2020\/002630"]}],"id":[{"id":"10.13039\/501100001843","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Divers"],"DOI":"10.1007\/s11030-025-11395-0","type":"journal-article","created":{"date-parts":[[2025,11,18]],"date-time":"2025-11-18T09:37:55Z","timestamp":1763458675000},"page":"4511-4539","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Rational in silico design of PPAR\u03b3 agonists for type 2 diabetes: an integrated study using pharmacophore modeling, 3D-QSAR, molecular docking, MD simulations, DFT, and toxicity prediction"],"prefix":"10.1007","volume":"30","author":[{"given":"Tathagata","family":"Pradhan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ojasvi","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gita","family":"Chawla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,18]]},"reference":[{"issue":"2","key":"11395_CR1","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1038\/nrendo.2017.151","volume":"14","author":"Y Zheng","year":"2018","unstructured":"Zheng Y, Ley SH, Hu FB (2018) Global aetiology and epidemiology of type 2 diabetes mellitus and its complications. Nat Rev Endocrinol 14(2):88\u201398. https:\/\/doi.org\/10.1038\/nrendo.2017.151","journal-title":"Nat Rev Endocrinol"},{"key":"11395_CR2","first-page":"1","volume-title":"Handbook of global health","author":"P Arokiasamy","year":"2021","unstructured":"Arokiasamy P, Salvi S, Selvamani Y (2021) Global burden of diabetes mellitus. In: Haring R, Ganten D, Moeti M (eds) Handbook of global health. Springer, pp 1\u201344"},{"key":"11395_CR3","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2021.807548","volume":"12","author":"AD Dahl\u00e9n","year":"2022","unstructured":"Dahl\u00e9n AD, Dashi G, Maslov I, Attwood MM, Jonsson J, Trukhan V, Schi\u00f6th HB (2022) Trends in antidiabetic drug discovery: FDA approved drugs, new drugs in clinical trials and global sales. Front Pharmacol 12:807548. https:\/\/doi.org\/10.3389\/fphar.2021.807548","journal-title":"Front Pharmacol"},{"issue":"23","key":"11395_CR4","doi-asserted-by":"publisher","first-page":"2540","DOI":"10.2174\/1381612825666190716094852","volume":"25","author":"W Ahsan","year":"2019","unstructured":"Ahsan W (2019) The journey of thiazolidinediones as modulators of PPARs for the management of diabetes: a current perspective. Curr Pharm Des 25(23):2540\u20132554. https:\/\/doi.org\/10.2174\/1381612825666190716094852","journal-title":"Curr Pharm Des"},{"key":"11395_CR5","doi-asserted-by":"publisher","first-page":"1069718","DOI":"10.1155\/2017\/1069718","volume":"1","author":"N Thangavel","year":"2017","unstructured":"Thangavel N, Al Bratty M, Akhtar Javed S, Ahsan W (2017) Alhazmi HA (2017) Targeting peroxisome proliferator-activated receptors using thiazolidinediones: strategy for design of novel antidiabetic drugs. Int J Med Chem 1:1069718. https:\/\/doi.org\/10.1155\/2017\/1069718","journal-title":"Int J Med Chem"},{"key":"11395_CR6","doi-asserted-by":"publisher","unstructured":"Singh G, Kumar R, DS D, Chaudhary M, Kaur C, Khurrana N (2024) Thiazolidinedione as a promising medicinal scaffold for the treatment of type 2 diabetes. Curr Diabetes Rev 20(6):89\u2013109. https:\/\/doi.org\/10.2174\/0115733998254798231005095627","DOI":"10.2174\/0115733998254798231005095627"},{"issue":"50","key":"11395_CR7","doi-asserted-by":"publisher","first-page":"15418","DOI":"10.1021\/acs.jpcb.5b09824","volume":"119","author":"MR Batista","year":"2015","unstructured":"Batista MR, Mart\u00ednez L (2015) Conformational diversity of the helix 12 of the ligand binding domain of PPAR\u03b3 and functional implications. J Phys Chem B 119(50):15418\u201315429. https:\/\/doi.org\/10.1021\/acs.jpcb.5b09824","journal-title":"J Phys Chem B"},{"issue":"10","key":"11395_CR8","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1016\/j.tips.2015.06.010","volume":"36","author":"S Sauer","year":"2015","unstructured":"Sauer S (2015) Ligands for the nuclear peroxisome proliferator-activated receptor gamma. Trends Pharmacol Sci 36(10):688\u2013704. https:\/\/doi.org\/10.1016\/j.tips.2015.06.010","journal-title":"Trends Pharmacol Sci"},{"issue":"1","key":"11395_CR9","doi-asserted-by":"publisher","first-page":"34792","DOI":"10.1038\/srep34792","volume":"6","author":"D Capelli","year":"2016","unstructured":"Capelli D, Cerchia C, Montanari R, Loiodice F, Tortorella P, Laghezza A, Cervoni L, Pochetti G, Lavecchia A (2016) Structural basis for PPAR partial or full activation revealed by a novel ligand binding mode. Sci Rep 6(1):34792. https:\/\/doi.org\/10.1038\/srep34792","journal-title":"Sci Rep"},{"key":"11395_CR10","doi-asserted-by":"publisher","DOI":"10.1155\/2015\/816856","volume":"1","author":"AJ Kroker","year":"2015","unstructured":"Kroker AJ, Bruning JB (2015) Review of the structural and dynamic mechanisms of PPAR\u03b3 partial agonism. PPAR Res 1:816856. https:\/\/doi.org\/10.1155\/2015\/816856","journal-title":"PPAR Res"},{"issue":"4","key":"11395_CR11","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24043940","volume":"24","author":"H Miyachi","year":"2023","unstructured":"Miyachi H (2023) Structural biology inspired development of a series of human peroxisome proliferator-activated receptor gamma (PPAR\u03b3) ligands: from agonist to antagonist. Int J Mol Sci 24(4):3940. https:\/\/doi.org\/10.3390\/ijms24043940","journal-title":"Int J Mol Sci"},{"issue":"4","key":"11395_CR12","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1021\/ci3006148","volume":"53","author":"I Kouskoumvekaki","year":"2013","unstructured":"Kouskoumvekaki I, Petersen RK, Fratev F, Taboureau O, Nielsen TE, Oprea TI, Sonne SB, Flindt EN, Jonsdottir SO, Kristiansen K (2013) Discovery of a novel selective PPAR\u03b3 ligand with partial agonist binding properties by integrated in silico\/in vitro work flow. J Chem Inf Model 53(4):923\u2013937. https:\/\/doi.org\/10.1021\/ci3006148","journal-title":"J Chem Inf Model"},{"issue":"10","key":"11395_CR13","doi-asserted-by":"publisher","first-page":"1258","DOI":"10.1016\/j.str.2007.07.014","volume":"15","author":"JB Bruning","year":"2007","unstructured":"Bruning JB, Chalmers MJ, Prasad S, Busby SA, Kamenecka TM, He Y, Nettles KW, Griffin PR (2007) Partial agonists activate PPAR\u03b3 using a helix 12 independent mechanism. Structure 15(10):1258\u20131271. https:\/\/doi.org\/10.1016\/j.str.2007.07.014","journal-title":"Structure"},{"issue":"2","key":"11395_CR14","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0055889","volume":"8","author":"L Guasch","year":"2013","unstructured":"Guasch L, Sala E, Mulero M, Valls C, Salvad\u00f3 MJ, Pujadas G, Garcia-Vallve S (2013) Identification of PPARgamma partial agonists of natural origin (II): in silico prediction in natural extracts with known antidiabetic activity. PLoS ONE 8(2):e55889. https:\/\/doi.org\/10.1371\/journal.pone.0055889","journal-title":"PLoS ONE"},{"issue":"06","key":"11395_CR15","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1055\/s-0034-1383119","volume":"81","author":"RB El-Houri","year":"2015","unstructured":"El-Houri RB, Mortier J, Murgueitio MS, Wolber G, Christensen LP (2015) Identification of PPAR\u03b3 agonists from natural sources using different in silico approaches. Planta Med 81(06):488\u2013494. https:\/\/doi.org\/10.1055\/s-0034-1383119","journal-title":"Planta Med"},{"key":"11395_CR16","doi-asserted-by":"publisher","DOI":"10.2147\/DDDT.S93449","author":"JA Encinar","year":"2015","unstructured":"Encinar JA, Fern\u00e1ndez-Ballester G, Galiano-Ibarra V, Micol V (2015) In silico approach for the discovery of new PPAR\u03b3 modulators among plant-derived polyphenols. Drug Des Devel Ther. https:\/\/doi.org\/10.2147\/DDDT.S93449","journal-title":"Drug Des Devel Ther"},{"key":"11395_CR17","doi-asserted-by":"publisher","unstructured":"Bairy PS, Gahtori P, Mishra A, Ram V Ligand based pharmacophore modeling and virtual screening for novel antidiabetics targeting PPAR-gamma. https:\/\/doi.org\/10.35940\/ijitee.D1005.0384S319","DOI":"10.35940\/ijitee.D1005.0384S319"},{"key":"11395_CR18","doi-asserted-by":"publisher","DOI":"10.1007\/s11030-025-11310-7","author":"MJ Alam","year":"2025","unstructured":"Alam MJ, Jamal A, Hussain SD, Ahamad S, Gupta D, Haque A (2025) Identification of new dasatinib analogues targeting mutated BCR-ABL1: virtual screening, molecular docking, and dynamics simulations studies. Mol Divers. https:\/\/doi.org\/10.1007\/s11030-025-11310-7","journal-title":"Mol Divers"},{"issue":"3","key":"11395_CR19","doi-asserted-by":"publisher","first-page":"1969","DOI":"10.1007\/s11030-024-10953-2","volume":"29","author":"SO Alshammari","year":"2025","unstructured":"Alshammari SO, Alshammari QA (2025) Natural product-derived ALK inhibitors for treating ALK-driven lung cancers: an in silico study. Mol Divers 29(3):1969\u20131982. https:\/\/doi.org\/10.1007\/s11030-024-10953-2","journal-title":"Mol Divers"},{"issue":"3","key":"11395_CR20","doi-asserted-by":"publisher","first-page":"2517","DOI":"10.1007\/s11030-024-11007-3","volume":"29","author":"A Das","year":"2025","unstructured":"Das A, Biggs MA, Hunt HL, Mahabadi V, Goncalves BG, Phan CAN, Banerjee IA (2025) Design and investigation of novel iridoid-based peptide conjugates for targeting EGFR and its mutants L858R and T790M\/L858R\/C797S: an in silico study. Mol Divers 29(3):2517\u20132541. https:\/\/doi.org\/10.1007\/s11030-024-11007-3","journal-title":"Mol Divers"},{"issue":"2","key":"11395_CR21","doi-asserted-by":"publisher","first-page":"1014","DOI":"10.1007\/s12010-022-04190-2","volume":"195","author":"Y Li","year":"2023","unstructured":"Li Y, Ks N, Byran G, Krishnamurthy PT (2023) Identification of selective PPAR-\u03b3 modulators by combining pharmacophore modeling, molecular docking, and adipogenesis assay. Appl Biochem Biotechnol 195(2):1014\u20131041. https:\/\/doi.org\/10.1007\/s12010-022-04190-2","journal-title":"Appl Biochem Biotechnol"},{"key":"11395_CR22","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1007\/s00044-016-1727-3","volume":"26","author":"A Nandy","year":"2017","unstructured":"Nandy A, Roy K, Saha A (2017) Structural exploration of PPAR\u03b3 modulators through pharmacophore mapping, fragment-based design, docking, and molecular dynamics simulation analyses. Med Chem Res 26:52\u201363. https:\/\/doi.org\/10.1007\/s00044-016-1727-3","journal-title":"Med Chem Res"},{"key":"11395_CR23","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1007\/s10822-015-9831-x","volume":"29","author":"SN Lewis","year":"2015","unstructured":"Lewis SN, Garcia Z, Hontecillas R, Bassaganya-Riera J, Bevan DR (2015) Pharmacophore modeling improves virtual screening for novel peroxisome proliferator-activated receptor-gamma ligands. J Comput Aided Mol Des 29:421\u2013439. https:\/\/doi.org\/10.1007\/s10822-015-9831-x","journal-title":"J Comput Aided Mol Des"},{"issue":"6","key":"11395_CR24","doi-asserted-by":"publisher","first-page":"2663","DOI":"10.1080\/07391102.2020.1841677","volume":"40","author":"P Prabitha","year":"2022","unstructured":"Prabitha P, Shanmugarajan D, Kumar TDA, Kumar BP (2022) Multi-conformational frame from molecular dynamics as a structure-based pharmacophore model for mapping, screening and identifying ligands against PPAR-\u03b3: a new protocol to develop promising candidates. J Biomol Struct Dyn 40(6):2663\u20132673. https:\/\/doi.org\/10.1080\/07391102.2020.1841677","journal-title":"J Biomol Struct Dyn"},{"key":"11395_CR25","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1007\/s10822-010-9398-5","volume":"25","author":"RK Petersen","year":"2011","unstructured":"Petersen RK, Christensen KB, Assimopoulou AN, Frett\u00e9 X, Papageorgiou VP, Kristiansen K, Kouskoumvekaki I (2011) Pharmacophore-driven identification of PPAR\u03b3 agonists from natural sources. J Comput Aided Mol Des 25:107\u2013116. https:\/\/doi.org\/10.1007\/s10822-010-9398-5","journal-title":"J Comput Aided Mol Des"},{"issue":"6","key":"11395_CR26","doi-asserted-by":"publisher","first-page":"2246","DOI":"10.1021\/acs.jmedchem.7b01285","volume":"61","author":"B Boubia","year":"2018","unstructured":"Boubia B, Poupardin O, Barth M, Binet J, Peralba P, Mounier L, Jacquier E, Gauthier E, Lepais V, Chatar M (2018) Design, synthesis, and evaluation of a novel series of indole sulfonamide peroxisome proliferator activated receptor (PPAR) \u03b1\/\u03b3\/\u03b4 triple activators: discovery of lanifibranor, a new antifibrotic clinical candidate. J Med Chem 61(6):2246\u20132265. https:\/\/doi.org\/10.1021\/acs.jmedchem.7b01285","journal-title":"J Med Chem"},{"issue":"10","key":"11395_CR27","doi-asserted-by":"publisher","first-page":"6949","DOI":"10.1021\/acs.jmedchem.1c00491","volume":"64","author":"K Tilekar","year":"2021","unstructured":"Tilekar K, Hess JD, Upadhyay N, Bianco AL, Schweipert M, Laghezza A, Loiodice F, Meyer-Almes F-J, Aguilera RJ, Lavecchia A (2021) Thiazolidinedione \u201cmagic bullets\u201d simultaneously targeting PPAR\u03b3 and HDACs: Design, synthesis, and investigations of their in vitro and in vivo antitumor effects. J Med Chem 64(10):6949\u20136971. https:\/\/doi.org\/10.1021\/acs.jmedchem.1c00491","journal-title":"J Med Chem"},{"issue":"13","key":"11395_CR28","doi-asserted-by":"publisher","first-page":"4457","DOI":"10.1021\/jm0502135","volume":"48","author":"GQ Shi","year":"2005","unstructured":"Shi GQ, Dropinski JF, McKeever BM, Xu S, Becker JW, Berger JP, MacNaul KL, Elbrecht A, Zhou G, Doebber TW (2005) Design and synthesis of \u03b1-aryloxyphenylacetic acid derivatives: a novel class of PPAR\u03b1\/\u03b3 dual agonists with potent antihyperglycemic and lipid modulating activity. J Med Chem 48(13):4457\u20134468. https:\/\/doi.org\/10.1021\/jm0502135","journal-title":"J Med Chem"},{"key":"11395_CR29","doi-asserted-by":"publisher","DOI":"10.1016\/j.bioorg.2020.103867","volume":"100","author":"P Kaur","year":"2020","unstructured":"Kaur P, Bhat ZR, Bhat S, Kumar R, Kumar R, Tikoo K, Gupta J, Khurana N, Kaur J, Khatik GL (2020) Synthesis and evaluation of new 1, 2, 4-oxadiazole based trans-acrylic acid derivatives as potential PPAR-alpha\/gamma dual agonist. Bioorg Chem 100:103867. https:\/\/doi.org\/10.1016\/j.bioorg.2020.103867","journal-title":"Bioorg Chem"},{"key":"11395_CR30","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1016\/j.ejmech.2018.09.071","volume":"159","author":"Z Li","year":"2018","unstructured":"Li Z, Zhou Z, Deng F, Li Y, Zhang D, Zhang L (2018) Design, synthesis, and biological evaluation of novel pan agonists of FFA1, PPAR\u03b3 and PPAR\u03b4. Eur J Med Chem 159:267\u2013276. https:\/\/doi.org\/10.1016\/j.ejmech.2018.09.071","journal-title":"Eur J Med Chem"},{"key":"11395_CR31","doi-asserted-by":"publisher","DOI":"10.1016\/j.bioorg.2020.103963","volume":"101","author":"Q Ren","year":"2020","unstructured":"Ren Q, Deng L, Zhou Z, Wang X, Hu L, Xie R, Li Z (2020) Design, synthesis, and biological evaluation of novel dual PPAR\u03b1\/\u03b4 agonists for the treatment of T2DM. Bioorg Chem 101:103963. https:\/\/doi.org\/10.1016\/j.bioorg.2020.103963","journal-title":"Bioorg Chem"},{"key":"11395_CR32","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/j.ejmech.2015.12.049","volume":"109","author":"KM Darwish","year":"2016","unstructured":"Darwish KM, Salama I, Mostafa S, Gomaa MS, Helal MA (2016) Design, synthesis, and biological evaluation of novel thiazolidinediones as PPAR\u03b3\/FFAR1 dual agonists. Eur J Med Chem 109:157\u2013172. https:\/\/doi.org\/10.1016\/j.ejmech.2015.12.049","journal-title":"Eur J Med Chem"},{"issue":"6","key":"11395_CR33","doi-asserted-by":"publisher","first-page":"2021","DOI":"10.1080\/07391102.2020.1750485","volume":"39","author":"BM Shah","year":"2021","unstructured":"Shah BM, Modi P, Trivedi P (2021) Pharmacophore-based virtual screening, 3D-QSAR, molecular docking approach for identification of potential dipeptidyl peptidase IV inhibitors. J Biomol Struct Dyn 39(6):2021\u20132043. https:\/\/doi.org\/10.1080\/07391102.2020.1750485","journal-title":"J Biomol Struct Dyn"},{"issue":"5","key":"11395_CR34","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1111\/j.1747-0285.2006.00384.x","volume":"67","author":"SL Dixon","year":"2006","unstructured":"Dixon SL, Smondyrev AM, Rao SN (2006) PHASE: a novel approach to pharmacophore modeling and 3D database searching. Chem Biol Drug Des 67(5):370\u2013372. https:\/\/doi.org\/10.1111\/j.1747-0285.2006.00384.x","journal-title":"Chem Biol Drug Des"},{"key":"11395_CR35","doi-asserted-by":"publisher","DOI":"10.1080\/07391102.2019.1615002","author":"J Vora","year":"2020","unstructured":"Vora J, Patel S, Athar M, Sinha S, Chhabria MT, Jha PC, Shrivastava N (2020) Pharmacophore modeling, molecular docking and molecular dynamics simulation for screening and identifying anti-dengue phytocompounds. J Biomol Struct Dyn. https:\/\/doi.org\/10.1080\/07391102.2019.1615002","journal-title":"J Biomol Struct Dyn"},{"issue":"10\u201311","key":"11395_CR36","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1007\/s10822-006-9087-6","volume":"20","author":"SL Dixon","year":"2006","unstructured":"Dixon SL, Smondyrev AM, Knoll EH, Rao SN, Shaw DE, Friesner RA (2006) PHASE: a new engine for pharmacophore perception, 3D QSAR model development, and 3D database screening: 1. Methodology and preliminary results. J Comput Aided Mol Des 20(10\u201311):647\u2013671. https:\/\/doi.org\/10.1007\/s10822-006-9087-6","journal-title":"J Comput Aided Mol Des"},{"key":"11395_CR37","unstructured":"F. B (2025) Dekois test dataset. Available from https:\/\/figshare.com\/articles\/dataset\/Dekois_test_dataset\/27967422?file=50994021. [Accessed 09-05-2025]"},{"key":"11395_CR38","doi-asserted-by":"publisher","DOI":"10.1016\/j.crstbi.2024.100124","volume":"7","author":"B Saha","year":"2024","unstructured":"Saha B, Das A, Jangid K, Kumar A, Kumar V, Jaitak V (2024) Identification of coumarin derivatives targeting acetylcholinesterase for Alzheimer\u2019s disease by field-based 3D-QSAR, pharmacophore model-based virtual screening, molecular docking, MM\/GBSA, ADME and MD simulation study. Curr Res Struct Biol 7:100124. https:\/\/doi.org\/10.1016\/j.crstbi.2024.100124","journal-title":"Curr Res Struct Biol"},{"key":"11395_CR39","doi-asserted-by":"publisher","first-page":"511","DOI":"10.37285\/ijddd.2.3.1","volume":"2","author":"R Veerasamy","year":"2011","unstructured":"Veerasamy R, Rajak H, Jain A, Sivadasan S, Christapher PV, Agrawal R (2011) Validation of QSAR Models - Strategies and Importance. Int J Drug Design and Discov 2:511\u2013519. https:\/\/doi.org\/10.37285\/ijddd.2.3.1","journal-title":"Int J Drug Design and Discov"},{"key":"11395_CR40","doi-asserted-by":"publisher","DOI":"10.1155\/2013\/306081","volume":"2013","author":"S Sharma","year":"2013","unstructured":"Sharma S, Basu A, Agrawal RK (2013) Pharmacophore modeling and docking studies on some nonpeptide-based caspase-3 inhibitors. Biomed Res Int 2013:306081. https:\/\/doi.org\/10.1155\/2013\/306081","journal-title":"Biomed Res Int"},{"issue":"10","key":"11395_CR41","doi-asserted-by":"publisher","first-page":"840","DOI":"10.2174\/138620711797537102","volume":"14","author":"P Badrinarayan","year":"2011","unstructured":"Badrinarayan P, Narahari Sastry G (2011) Virtual high throughput screening in new lead identification. Comb Chem High Throughput Screen 14(10):840\u2013860. https:\/\/doi.org\/10.2174\/138620711797537102","journal-title":"Comb Chem High Throughput Screen"},{"issue":"11","key":"11395_CR42","doi-asserted-by":"publisher","first-page":"2401","DOI":"10.1039\/D3MD00273J","volume":"14","author":"MG Srinivasa","year":"2023","unstructured":"Srinivasa MG, Revanasiddappa B, Prabhu A, Rani V, Ghate SD, BR PK (2023) Development of novel thiazolidine-2, 4-dione derivatives as PPAR-\u03b3 agonists through design, synthesis, computational docking, MD simulation, and comprehensive in vitro and in vivo evaluation. RSC Med Chem 14(11):2401\u20132416. https:\/\/doi.org\/10.1039\/D3MD00273J","journal-title":"RSC Med Chem"},{"issue":"9","key":"11395_CR43","doi-asserted-by":"publisher","first-page":"2672","DOI":"10.3390\/ijms24043940","volume":"38","author":"Y-Y Liu","year":"2020","unstructured":"Liu Y-Y, Feng X-Y, Jia W-Q, Jing Z, Xu W-R, Cheng X-C (2020) Virtual identification of novel PPAR\u03b1\/\u03b3 dual agonists by 3D-QSAR, molecule docking and molecular dynamics studies. J Biomol Struct Dyn 38(9):2672\u20132685. https:\/\/doi.org\/10.3390\/ijms24043940","journal-title":"J Biomol Struct Dyn"},{"key":"11395_CR44","doi-asserted-by":"publisher","DOI":"10.1016\/j.molstruc.2021.130962","volume":"1244","author":"M Chaabene","year":"2021","unstructured":"Chaabene M, Agren S, El Haskouri J, Allouche A-R, Mohamed L, Cha\u00e2bane RB, Baouab MHV (2021) Spectroscopic characterization and binding interaction of heavy metal onto the surface receptor of the azobenzene: DFT and experimental approach. J Mol Struct 1244:130962. https:\/\/doi.org\/10.1016\/j.molstruc.2021.130962","journal-title":"J Mol Struct"},{"key":"11395_CR45","doi-asserted-by":"publisher","DOI":"10.1016\/j.molstruc.2020.128715","volume":"1220","author":"MA Mumit","year":"2020","unstructured":"Mumit MA, Pal TK, Alam MA, Islam MA-A-A-A, Paul S, Sheikh MC (2020) DFT studies on vibrational and electronic spectra, HOMO\u2013LUMO, MEP, HOMA, NBO and molecular docking analysis of benzyl-3-N-(2, 4, 5-trimethoxyphenylmethylene) hydrazinecarbodithioate. J Mol Struct 1220:128715. https:\/\/doi.org\/10.1016\/j.molstruc.2020.128715","journal-title":"J Mol Struct"},{"issue":"16","key":"11395_CR46","doi-asserted-by":"publisher","first-page":"18469","DOI":"10.1021\/acsomega.4c00543","volume":"9","author":"A I\u015f\u0131k","year":"2024","unstructured":"I\u015f\u0131k A, \u00c7evik UA, Karayel A, Ahmad I, Patel H, \u00c7elik \u0130, G\u00fcl \u00dcD, Bayaz\u0131t G, Bostanc\u0131 HE, Ko\u00e7ak A (2024) Synthesis, DFT calculations, in silico studies, and antimicrobial evaluation of benzimidazole-thiadiazole derivatives. ACS Omega 9(16):18469. https:\/\/doi.org\/10.1021\/acsomega.4c00543","journal-title":"ACS Omega"},{"issue":"26","key":"11395_CR47","doi-asserted-by":"publisher","first-page":"7512","DOI":"10.1021\/ja00364a005","volume":"105","author":"RG Parr","year":"1983","unstructured":"Parr RG, Pearson RG (1983) Absolute hardness: companion parameter to absolute electronegativity. J Am Chem Soc 105(26):7512\u20137516. https:\/\/doi.org\/10.1021\/ja00364a005","journal-title":"J Am Chem Soc"},{"key":"11395_CR48","doi-asserted-by":"publisher","DOI":"10.1016\/j.bioorg.2022.105850","volume":"125","author":"MA Hosen","year":"2022","unstructured":"Hosen MA, Munia NS, Al-Ghorbani M, Baashen M, Almalki FA, Hadda TB, Ali F, Mahmud S, Saleh MA, Laaroussi H (2022) Synthesis, antimicrobial, molecular docking and molecular dynamics studies of lauroyl thymidine analogs against SARS-CoV-2: POM study and identification of the pharmacophore sites. Bioorg Chem 125:105850. https:\/\/doi.org\/10.1016\/j.bioorg.2022.105850","journal-title":"Bioorg Chem"},{"issue":"W1","key":"11395_CR49","doi-asserted-by":"publisher","first-page":"W513","DOI":"10.1093\/nar\/gkae303","volume":"52","author":"P Banerjee","year":"2024","unstructured":"Banerjee P, Kemmler E, Dunkel M, Preissner R (2024) ProTox 3.0: a webserver for the prediction of toxicity of chemicals. Nucleic Acids Res 52(W1):W513\u2013W520. https:\/\/doi.org\/10.1093\/nar\/gkae303","journal-title":"Nucleic Acids Res"},{"issue":"1","key":"11395_CR50","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1080\/15376516.2024.2382815","volume":"35","author":"P Banerjee","year":"2025","unstructured":"Banerjee P, Ulker O, Ozkan I, Ulker OC (2025) The investigation of the toxicity of organophosphorus flame retardants (OPFRs) by using in silico toxicity prediction platform ProTox-3.0. Toxicol Mech Methods 35(1):32\u201342. https:\/\/doi.org\/10.1080\/15376516.2024.2382815","journal-title":"Toxicol Mech Methods"}],"container-title":["Molecular Diversity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11030-025-11395-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11030-025-11395-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11030-025-11395-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,23]],"date-time":"2026-05-23T11:33:19Z","timestamp":1779535999000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11030-025-11395-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,18]]},"references-count":50,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2026,6]]}},"alternative-id":["11395"],"URL":"https:\/\/doi.org\/10.1007\/s11030-025-11395-0","relation":{},"ISSN":["1573-501X"],"issn-type":[{"value":"1573-501X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,18]]},"assertion":[{"value":"18 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}